These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9093190)

  • 1. Lack of an ovarian function influence on the increased adrenal androgen secretion present in women with functional ovarian hyperandrogenism.
    Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho JM; Varela C
    Fertil Steril; 1997 Apr; 67(4):654-62. PubMed ID: 9093190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17 alpha.
    Escobar-Morreale H; Pazos F; Potau N; García-Robles R; Sancho JM; Varela C
    Fertil Steril; 1994 Sep; 62(3):521-30. PubMed ID: 8062947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in the serum insulin-like growth factor-1 axis in women with hyperandrogenism.
    Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Varela C; Sancho JM
    Fertil Steril; 1998 Dec; 70(6):1090-100. PubMed ID: 9848301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
    Bidzińska B; Tworowska U; Demissie M; Milewicz A
    Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation.
    Azziz R; Bradley EL; Potter HD; Boots LR
    J Clin Endocrinol Metab; 1995 Feb; 80(2):400-5. PubMed ID: 7852496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations.
    Escobar-Morreale HF; San Millán JL; Smith RR; Sancho J; Witchel SF
    Fertil Steril; 1999 Oct; 72(4):629-38. PubMed ID: 10521100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian influence on adrenal androgen secretion in polycystic ovary syndrome.
    Fruzzetti F; De Lorenzo D; Ricci C; Teti G
    Fertil Steril; 1995 Apr; 63(4):734-41. PubMed ID: 7890056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.
    Rosenfield RL; Barnes RB; Ehrmann DA
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1686-92. PubMed ID: 7989476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome.
    Gonzalez F; Chang L; Horab T; Stanczyk FZ; Crickard K; Lobo RA
    Fertil Steril; 1999 Mar; 71(3):439-44. PubMed ID: 10065779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function.
    Escobar-Morreale HF; Serrano-Gotarredona J; Avila S; Villar-Palasí J; Varela C; Sancho J
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2580-4. PubMed ID: 9661648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of functional ovarian hyperandrogenism and polycystic ovary syndrome in patients with hyperandrogenism.
    Cetinkaya E; Ocal G; Berberoğlu M; Adiyaman P
    J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1011-6. PubMed ID: 14513878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism.
    Azziz R; Rafi A; Smith BR; Bradley EL; Zacur HA
    J Clin Endocrinol Metab; 1990 Feb; 70(2):431-6. PubMed ID: 2137133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
    Moran C; Reyna R; Boots LS; Azziz R
    Fertil Steril; 2004 Jan; 81(1):126-31. PubMed ID: 14711555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for heterogeneous etiologies of adrenal dysfunction in polycystic ovary syndrome.
    Gonzalez F; Chang L; Horab T; Lobo RA
    Fertil Steril; 1996 Sep; 66(3):354-61. PubMed ID: 8751729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism.
    Rossi R; Tauchmanovà L; Luciano A; Valentino R; Savastano S; Battista C; Di Martino M; Lombardi G
    J Endocrinol Invest; 2001; 24(7):491-8. PubMed ID: 11508782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome.
    Zhou R; Bird IM; Dumesic DA; Abbott DH
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6630-7. PubMed ID: 16174719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term remission of ovarian hyperandrogenism after short-term treatment with a gonadotropin-releasing hormone agonist.
    Efstathiadou Z; Tsatsoulis A
    Fertil Steril; 2001 Jan; 75(1):59-62. PubMed ID: 11163817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.